We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University
News

BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University

BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University
News

BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BSD Medical Corp. has announced that the company has signed an exclusive patent license agreement with Duke University for rights to Duke’s treatment system for primary breast cancer using hyperthermia therapy.

This breast treatment system has been used and tested at Duke University Medical Center over several years. BSD intends to integrate this technology with its current BSD-2000 and BSD-500 hyperthermia systems. The technology will be used to complement radiation therapy, chemotherapy, and heat released, targeted liposome drug delivery.

One of BSD Medical’s areas of focus is breast cancer (the number one cancer contracted by women), and BSD has been rapidly expanding the breadth of its technologies for breast cancer treatment.

Advertisement